Introducing Optifolin+®: Balchem Unveils the Launch of Optifolin+®
Infusion set,Disposable Syringe,Insulin Syringe,gauze roll,Cotton roll,Sterile Urine cup FOSHAN PHARMA CO., LTD. , https://www.forepharm.com
Montvale, New Jersey (May 20, 2024) – As a global leader in specialty ingredients for human nutrition and health, we are excited to announce the launch of Optifolin®+ — a groundbreaking choline-enriched folate ingredient designed to revolutionize the U.S. dietary supplement market.
Optifolin®+ is a bioactive form of L-5-methyltetrahydrofolate (L-5-MTHF), combined with our premium choline source, VitaCholine®. This unique formulation supports cellular health across all life stages, from pregnancy and child development to adulthood. It offers superior stability, solubility, and performance, making it an ideal choice for supplement manufacturers looking to create innovative, high-quality products.
According to Frederic Boned, Sr. Vice President & GM of Balchem Human Nutrition and Health:
*"We’re thrilled to introduce Optifolin®+ at a time when women’s health is gaining more attention than ever. Folate plays a critical role in supporting maternal and fetal health, and Optifolin®+ stands out as the first choline-enriched folate on the market. With seven times the methyl groups compared to other folate products, it offers enhanced support for DNA synthesis, brain function, and heart health."*
Optifolin®+ is a patented form of L-5-methylfolate with 98% active methylating nutrients. Unlike folic acid, it is biologically active and doesn’t require conversion in the body, reducing the risk of unmetabolized folic acid accumulation. This makes it a safer and more effective option for meeting Vitamin B9 requirements throughout life.
The combination of choline and L-5-MTHF also enhances product formulation, offering better stability, solubility, and shelf life. This opens up new possibilities for tablets, capsules, sachets, and stick packs — making it easier for brands to develop convenient, consumer-friendly solutions.
Dominik Mattern, VP Science, Business Development and Marketing at Balchem Human Nutrition and Health, added:
*"The supplement industry is shifting toward personalized solutions, and Optifolin®+ is perfectly positioned to meet this demand. With its unique formulation and strong regulatory backing, including NDIN approval and patent protection, we believe Optifolin®+ will become a key player in the future of health and wellness."*
By partnering with Balchem, manufacturers can tap into our deep expertise and deliver cutting-edge products that help consumers achieve their wellness goals at every stage of life.
For more information about Optifolin®+ and Balchem’s full range of ingredients, visit our website today.
[Learn More About Optifolin®+]
---
**References:**
[1] Nutrition Business Journal 2023 Condition Specific Report
[2] Food and Nutrition Board, Institute of Medicine, 1998
[3] Code of Federal Regulation, Part 101 – Food Labelling, Health claims: Folate and neural tube defects. Available at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101#101.79